Sonnagen continues to be very active in Peptides Europe Market today as we gained experience through contract manufacturing for years.
Our Research & Development studies combine a team with 20 years of experience with the latest technology that enabled us to offer the highest quality and purity of peptides
Sonnagen has set as its main objective, to produce only quality peptides, which also would have an acceptable price, based on the economic situation. and by important of donations offered by medical institutions the company represents a model of corporate responsibility, alternatively contributing to achievement of the task.
